Janumet

Metformin Hydrochloride,

Sitagliptin Phosphate

4.7 Moderate risk

Janumet & Pancreatic carcinoma

6.6%

of users reported Pancreatic carcinoma

45.8%

also reported Severe reaction

59.6%

are men

Most common medical consequences

Severe reaction
45.8%
Death
43.1%
Hospitalization
5.8%
Life-threatening condition
3.8%
Disability
1.5%

Have you experienced any negative side effects from this medication?

Janumet: general information

Most common side effects (115)

Most commonly affected ages

30 - 39 years
0.5%
40 - 49 years
7.0%
50 - 59 years
21.2%
60 - 69 years
34.8%
70 - 79 years
26.5%
80 - 89 years
10.1%